

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 6.69306681 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 5.52575278 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.52575278 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.47132217 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.47132217 |
| 6 | phenylpropanoid metabolic process (GO:0009698) | 5.07086573 |
| 7 | glyoxylate metabolic process (GO:0046487) | 5.05961494 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.03824869 |
| 9 | urate metabolic process (GO:0046415) | 4.87902774 |
| 10 | omega-hydroxylase P450 pathway (GO:0097267) | 4.85605424 |
| 11 | drug transmembrane transport (GO:0006855) | 4.80580347 |
| 12 | cysteine metabolic process (GO:0006534) | 4.72659064 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.70516864 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.70516864 |
| 15 | tryptophan catabolic process (GO:0006569) | 4.70516864 |
| 16 | fibrinolysis (GO:0042730) | 4.55607632 |
| 17 | protein activation cascade (GO:0072376) | 4.53215451 |
| 18 | tryptophan metabolic process (GO:0006568) | 4.50861785 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.45846924 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.43372924 |
| 21 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.36625448 |
| 22 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.36625448 |
| 23 | lysine catabolic process (GO:0006554) | 4.25690708 |
| 24 | lysine metabolic process (GO:0006553) | 4.25690708 |
| 25 | blood coagulation, intrinsic pathway (GO:0007597) | 4.21156646 |
| 26 | kynurenine metabolic process (GO:0070189) | 4.18404513 |
| 27 | drug transport (GO:0015893) | 4.11772246 |
| 28 | hormone catabolic process (GO:0042447) | 4.03881268 |
| 29 | bile acid biosynthetic process (GO:0006699) | 4.02388226 |
| 30 | alkaloid metabolic process (GO:0009820) | 4.02134091 |
| 31 | bile acid and bile salt transport (GO:0015721) | 4.01964678 |
| 32 | valine metabolic process (GO:0006573) | 4.01929545 |
| 33 | drug catabolic process (GO:0042737) | 3.91503231 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 3.88095470 |
| 35 | regulation of bile acid biosynthetic process (GO:0070857) | 3.85192903 |
| 36 | alpha-linolenic acid metabolic process (GO:0036109) | 3.84765389 |
| 37 | oxidative demethylation (GO:0070989) | 3.84732290 |
| 38 | ethanol metabolic process (GO:0006067) | 3.84078649 |
| 39 | arginine metabolic process (GO:0006525) | 3.83784771 |
| 40 | negative regulation of protein activation cascade (GO:2000258) | 3.81284579 |
| 41 | complement activation, alternative pathway (GO:0006957) | 3.80042150 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 3.79737808 |
| 43 | negative regulation of hemostasis (GO:1900047) | 3.79737808 |
| 44 | angiotensin maturation (GO:0002003) | 3.77102080 |
| 45 | homocysteine metabolic process (GO:0050667) | 3.76377685 |
| 46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.69781556 |
| 47 | negative regulation of complement activation (GO:0045916) | 3.68956712 |
| 48 | protein carboxylation (GO:0018214) | 3.68823992 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.68823992 |
| 50 | urea cycle (GO:0000050) | 3.68159456 |
| 51 | urea metabolic process (GO:0019627) | 3.68159456 |
| 52 | ethanol oxidation (GO:0006069) | 3.65509116 |
| 53 | serine family amino acid catabolic process (GO:0009071) | 3.65441507 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 3.65418714 |
| 55 | cholesterol efflux (GO:0033344) | 3.63801991 |
| 56 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.61425556 |
| 57 | exogenous drug catabolic process (GO:0042738) | 3.60775333 |
| 58 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.58212248 |
| 59 | benzene-containing compound metabolic process (GO:0042537) | 3.56599988 |
| 60 | negative regulation of fibrinolysis (GO:0051918) | 3.53373317 |
| 61 | regulation of protein activation cascade (GO:2000257) | 3.53348921 |
| 62 | negative regulation of coagulation (GO:0050819) | 3.52967373 |
| 63 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.51970858 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51399273 |
| 65 | regulation of humoral immune response (GO:0002920) | 3.47257165 |
| 66 | nitrogen cycle metabolic process (GO:0071941) | 3.45108599 |
| 67 | negative regulation of wound healing (GO:0061045) | 3.43703043 |
| 68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41590844 |
| 69 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.41590844 |
| 70 | positive regulation of lipid catabolic process (GO:0050996) | 3.40010103 |
| 71 | regulation of complement activation (GO:0030449) | 3.37265542 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 3.35755225 |
| 73 | short-chain fatty acid metabolic process (GO:0046459) | 3.32506987 |
| 74 | regulation of plasminogen activation (GO:0010755) | 3.32043041 |
| 75 | tricarboxylic acid metabolic process (GO:0072350) | 3.30762869 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 3.30231989 |
| 77 | bile acid metabolic process (GO:0008206) | 3.30061425 |
| 78 | response to mercury ion (GO:0046689) | 3.29895773 |
| 79 | regulation of fibrinolysis (GO:0051917) | 3.29341386 |
| 80 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.27972541 |
| 81 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.27519920 |
| 82 | reverse cholesterol transport (GO:0043691) | 3.27398992 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 3.25611669 |
| 84 | flavonoid metabolic process (GO:0009812) | 3.25317314 |
| 85 | aldehyde catabolic process (GO:0046185) | 3.25074690 |
| 86 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.24561767 |
| 87 | fatty acid beta-oxidation (GO:0006635) | 3.22117419 |
| 88 | growth hormone receptor signaling pathway (GO:0060396) | 3.22082477 |
| 89 | tyrosine metabolic process (GO:0006570) | 3.21757942 |
| 90 | cellular glucuronidation (GO:0052695) | 3.20502948 |
| 91 | fatty acid oxidation (GO:0019395) | 3.20290358 |
| 92 | regulation of cholesterol esterification (GO:0010872) | 3.20231011 |
| 93 | carnitine metabolic process (GO:0009437) | 3.20059304 |
| 94 | heme transport (GO:0015886) | 3.19934108 |
| 95 | acute inflammatory response (GO:0002526) | 3.19804219 |
| 96 | amine catabolic process (GO:0009310) | 3.19167927 |
| 97 | cellular biogenic amine catabolic process (GO:0042402) | 3.19167927 |
| 98 | cellular amino acid catabolic process (GO:0009063) | 3.18499837 |
| 99 | fructose metabolic process (GO:0006000) | 3.18108620 |
| 100 | response to growth hormone (GO:0060416) | 3.17618706 |
| 101 | regulation of cholesterol homeostasis (GO:2000188) | 3.16920323 |
| 102 | plasma lipoprotein particle organization (GO:0071827) | 3.16782679 |
| 103 | serine family amino acid metabolic process (GO:0009069) | 3.14987008 |
| 104 | lipid oxidation (GO:0034440) | 3.14570988 |
| 105 | response to nitrosative stress (GO:0051409) | 3.14379897 |
| 106 | 2-oxoglutarate metabolic process (GO:0006103) | 3.13294788 |
| 107 | low-density lipoprotein particle remodeling (GO:0034374) | 3.13174993 |
| 108 | arginine catabolic process (GO:0006527) | 3.09986020 |
| 109 | xenobiotic catabolic process (GO:0042178) | 3.09142500 |
| 110 | branched-chain amino acid metabolic process (GO:0009081) | 3.08953199 |
| 111 | organic cation transport (GO:0015695) | 3.07587733 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.04915632 |
| 113 | uronic acid metabolic process (GO:0006063) | 3.04915632 |
| 114 | positive regulation of hemostasis (GO:1900048) | 3.04076811 |
| 115 | positive regulation of blood coagulation (GO:0030194) | 3.04076811 |
| 116 | steroid catabolic process (GO:0006706) | 3.02595477 |
| 117 | phospholipid efflux (GO:0033700) | 3.02266649 |
| 118 | protein-lipid complex subunit organization (GO:0071825) | 3.02152182 |
| 119 | complement activation, classical pathway (GO:0006958) | 3.01732472 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 3.00345371 |
| 121 | negative regulation of humoral immune response (GO:0002921) | 2.99670973 |
| 122 | regulation of triglyceride catabolic process (GO:0010896) | 2.98240712 |
| 123 | protein-lipid complex remodeling (GO:0034368) | 2.96095157 |
| 124 | macromolecular complex remodeling (GO:0034367) | 2.96095157 |
| 125 | plasma lipoprotein particle remodeling (GO:0034369) | 2.96095157 |
| 126 | carboxylic acid catabolic process (GO:0046395) | 2.95990445 |
| 127 | organic acid catabolic process (GO:0016054) | 2.95990445 |
| 128 | positive regulation of coagulation (GO:0050820) | 2.95188045 |
| 129 | fatty acid catabolic process (GO:0009062) | 2.94917151 |
| 130 | monocarboxylic acid catabolic process (GO:0072329) | 2.94057782 |
| 131 | acylglycerol homeostasis (GO:0055090) | 2.93695804 |
| 132 | triglyceride homeostasis (GO:0070328) | 2.93695804 |
| 133 | drug metabolic process (GO:0017144) | 2.93470498 |
| 134 | cellular response to growth hormone stimulus (GO:0071378) | 2.93167886 |
| 135 | surfactant homeostasis (GO:0043129) | 2.92319927 |
| 136 | cellular ketone body metabolic process (GO:0046950) | 2.92047641 |
| 137 | complement activation (GO:0006956) | 2.91954296 |
| 138 | acute-phase response (GO:0006953) | 2.89306036 |
| 139 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.89073348 |
| 140 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.89073348 |
| 141 | glutamate metabolic process (GO:0006536) | 2.88697190 |
| 142 | negative regulation of sterol transport (GO:0032372) | 2.87471289 |
| 143 | negative regulation of cholesterol transport (GO:0032375) | 2.87471289 |
| 144 | lipoprotein metabolic process (GO:0042157) | 2.87363121 |
| 145 | NADH metabolic process (GO:0006734) | 2.86321127 |
| 146 | negative regulation of lipase activity (GO:0060192) | 2.86240935 |
| 147 | xenobiotic metabolic process (GO:0006805) | 2.85355782 |
| 148 | intestinal absorption (GO:0050892) | 2.83609065 |
| 149 | plasma lipoprotein particle clearance (GO:0034381) | 2.83283644 |
| 150 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.80708702 |
| 151 | cholesterol homeostasis (GO:0042632) | 2.76757018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.87633064 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.78469285 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.05420737 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.59622397 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.44522699 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.35522399 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.72373756 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.28629546 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.25376831 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.63274107 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.57454131 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.41610171 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.31297863 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.30426756 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.29865855 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.28869916 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.24557213 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.18501424 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.17898320 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14781241 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04228286 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.94474642 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84033129 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75897707 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73615517 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58614324 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58561816 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57860051 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57701876 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56265803 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51676689 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50127534 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47868609 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44808626 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44186764 |
| 36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42788988 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42671347 |
| 38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.41364339 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40483425 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37958073 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35461105 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32226395 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29775884 |
| 44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26446492 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.26403776 |
| 46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26268429 |
| 47 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24616700 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.24252475 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22834211 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20863322 |
| 51 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.20811203 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19637612 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19129521 |
| 54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11268189 |
| 55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10399720 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10056932 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09449640 |
| 58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06712237 |
| 59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05140187 |
| 60 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04892052 |
| 61 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.03926006 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02497007 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02067105 |
| 64 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00160514 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99874875 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99497411 |
| 67 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98916036 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98751574 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96421888 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95436714 |
| 71 | MAF_26560356_Chip-Seq_TH1_Human | 0.95140442 |
| 72 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94630216 |
| 73 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93847945 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93014742 |
| 75 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.92950940 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91873713 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91263123 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90996642 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90991073 |
| 80 | SA1_27219007_Chip-Seq_Bcells_Human | 0.90592349 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90086471 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89319210 |
| 83 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88709763 |
| 84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.88599985 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.88123560 |
| 86 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.87871069 |
| 87 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87573837 |
| 88 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.87188017 |
| 89 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.87167706 |
| 90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86798415 |
| 91 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86221043 |
| 92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.82967794 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82956382 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82757457 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.82721871 |
| 96 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.81839480 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81298941 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81004994 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80634080 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80501597 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80428940 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80428713 |
| 103 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.80426584 |
| 104 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80200040 |
| 105 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.80106877 |
| 106 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80014312 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79702018 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79090516 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.78595001 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78081396 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77429768 |
| 112 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.76881190 |
| 113 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.75415892 |
| 114 | MYB_26560356_Chip-Seq_TH1_Human | 0.75103649 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74948166 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74899675 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74899675 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74648876 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74474180 |
| 120 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.72855925 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.72772065 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.72766632 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72580467 |
| 124 | MYB_26560356_Chip-Seq_TH2_Human | 0.72144305 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71963153 |
| 126 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71786837 |
| 127 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71742020 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71404138 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70704980 |
| 130 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.70414916 |
| 131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.70251121 |
| 132 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.69800418 |
| 133 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.69182716 |
| 134 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.68175567 |
| 135 | SPI1_23127762_ChIP-Seq_K562_Human | 0.67670036 |
| 136 | P300_27268052_Chip-Seq_Bcells_Human | 0.67615695 |
| 137 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.65978384 |
| 138 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.64693190 |
| 139 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.64660409 |
| 140 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.64582429 |
| 141 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.64511781 |
| 142 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64453437 |
| 143 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63547048 |
| 144 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.63436390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.62305938 |
| 2 | MP0005360_urolithiasis | 5.50254364 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 4.52203330 |
| 4 | MP0005365_abnormal_bile_salt | 3.91974117 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.82318259 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.80260642 |
| 7 | MP0003252_abnormal_bile_duct | 2.93280509 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 2.65183561 |
| 9 | MP0005332_abnormal_amino_acid | 2.59717835 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.54118493 |
| 11 | MP0002254_reproductive_system_inflammat | 2.39480828 |
| 12 | MP0003195_calcinosis | 2.25710213 |
| 13 | MP0009840_abnormal_foam_cell | 2.24764807 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.21993117 |
| 15 | MP0009643_abnormal_urine_homeostasis | 2.18724696 |
| 16 | MP0003724_increased_susceptibility_to | 2.11111104 |
| 17 | MP0000685_abnormal_immune_system | 1.99462913 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 1.97767006 |
| 19 | MP0005083_abnormal_biliary_tract | 1.92504826 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.88621390 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.86510615 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.78873063 |
| 23 | MP0010368_abnormal_lymphatic_system | 1.70924468 |
| 24 | MP0000604_amyloidosis | 1.64136310 |
| 25 | MP0000609_abnormal_liver_physiology | 1.63411554 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.59017206 |
| 27 | MP0003186_abnormal_redox_activity | 1.57041235 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 1.54841812 |
| 29 | MP0009764_decreased_sensitivity_to | 1.50484362 |
| 30 | MP0009785_altered_susceptibility_to | 1.50134961 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44212138 |
| 32 | MP0002136_abnormal_kidney_physiology | 1.42281046 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.40745040 |
| 34 | MP0001756_abnormal_urination | 1.39318929 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.37598226 |
| 36 | MP0009697_abnormal_copulation | 1.35715697 |
| 37 | MP0001765_abnormal_ion_homeostasis | 1.34219414 |
| 38 | MP0003303_peritoneal_inflammation | 1.33263967 |
| 39 | MP0008469_abnormal_protein_level | 1.29691001 |
| 40 | MP0004782_abnormal_surfactant_physiolog | 1.28099642 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.28097271 |
| 42 | MP0003436_decreased_susceptibility_to | 1.27706374 |
| 43 | MP0003879_abnormal_hair_cell | 1.25927580 |
| 44 | MP0001790_abnormal_immune_system | 1.22942286 |
| 45 | MP0005387_immune_system_phenotype | 1.22942286 |
| 46 | MP0005166_decreased_susceptibility_to | 1.22883421 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.21798886 |
| 48 | MP0001958_emphysema | 1.18607574 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.16903169 |
| 50 | MP0004043_abnormal_pH_regulation | 1.16834704 |
| 51 | MP0005025_abnormal_response_to | 1.11595361 |
| 52 | MP0001764_abnormal_homeostasis | 1.11576530 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.10835156 |
| 54 | MP0002928_abnormal_bile_duct | 1.09270882 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.08985354 |
| 56 | MP0005220_abnormal_exocrine_pancreas | 1.07906349 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.07553501 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.06782940 |
| 59 | MP0010386_abnormal_urinary_bladder | 1.06489737 |
| 60 | MP0001853_heart_inflammation | 1.05985379 |
| 61 | MP0000598_abnormal_liver_morphology | 1.02788159 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.02320995 |
| 63 | MP0005451_abnormal_body_composition | 1.01762804 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.01696239 |
| 65 | MP0003868_abnormal_feces_composition | 1.01687864 |
| 66 | MP0005535_abnormal_body_temperature | 0.99928150 |
| 67 | MP0001879_abnormal_lymphatic_vessel | 0.98745490 |
| 68 | MP0002419_abnormal_innate_immunity | 0.97609722 |
| 69 | MP0003638_abnormal_response/metabolism_ | 0.96906087 |
| 70 | MP0004264_abnormal_extraembryonic_tissu | 0.96667325 |
| 71 | MP0003690_abnormal_glial_cell | 0.94350271 |
| 72 | MP0009763_increased_sensitivity_to | 0.93572853 |
| 73 | MP0001873_stomach_inflammation | 0.93554657 |
| 74 | MP0002971_abnormal_brown_adipose | 0.93075529 |
| 75 | MP0001501_abnormal_sleep_pattern | 0.88858974 |
| 76 | MP0003329_amyloid_beta_deposits | 0.88659837 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.86548951 |
| 78 | MP0005671_abnormal_response_to | 0.82953199 |
| 79 | MP0001800_abnormal_humoral_immune | 0.78702365 |
| 80 | MP0005000_abnormal_immune_tolerance | 0.77988342 |
| 81 | MP0003075_altered_response_to | 0.76491007 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.76056095 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.75755913 |
| 84 | MP0006054_spinal_hemorrhage | 0.74099647 |
| 85 | MP0005376_homeostasis/metabolism_phenot | 0.74097143 |
| 86 | MP0002723_abnormal_immune_serum | 0.74016981 |
| 87 | MP0005448_abnormal_energy_balance | 0.72826407 |
| 88 | MP0002135_abnormal_kidney_morphology | 0.72680834 |
| 89 | MP0002452_abnormal_antigen_presenting | 0.72045726 |
| 90 | MP0003011_delayed_dark_adaptation | 0.71474664 |
| 91 | MP0005647_abnormal_sex_gland | 0.71338113 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.70807674 |
| 93 | MP0000249_abnormal_blood_vessel | 0.69580762 |
| 94 | MP0003705_abnormal_hypodermis_morpholog | 0.69166299 |
| 95 | MP0004947_skin_inflammation | 0.68878433 |
| 96 | MP0002006_tumorigenesis | 0.68358374 |
| 97 | MP0002168_other_aberrant_phenotype | 0.67810978 |
| 98 | MP0005164_abnormal_response_to | 0.67624905 |
| 99 | MP0008874_decreased_physiological_sensi | 0.67488528 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 0.67479903 |
| 101 | MP0009379_abnormal_foot_pigmentation | 0.65871282 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.65629479 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.65229717 |
| 104 | MP0006082_CNS_inflammation | 0.64853454 |
| 105 | MP0001881_abnormal_mammary_gland | 0.63549727 |
| 106 | MP0000343_altered_response_to | 0.63331423 |
| 107 | MP0001663_abnormal_digestive_system | 0.62694608 |
| 108 | MP0000538_abnormal_urinary_bladder | 0.61718781 |
| 109 | MP0002909_abnormal_adrenal_gland | 0.61548545 |
| 110 | MP0001664_abnormal_digestion | 0.61156678 |
| 111 | MP0005310_abnormal_salivary_gland | 0.60654387 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.60549786 |
| 113 | MP0001545_abnormal_hematopoietic_system | 0.60549786 |
| 114 | MP0005670_abnormal_white_adipose | 0.59861016 |
| 115 | MP0005408_hypopigmentation | 0.58767634 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.58671972 |
| 117 | MP0002405_respiratory_system_inflammati | 0.58436328 |
| 118 | MP0001819_abnormal_immune_cell | 0.57317030 |
| 119 | MP0002420_abnormal_adaptive_immunity | 0.56386356 |
| 120 | MP0004510_myositis | 0.55473907 |
| 121 | MP0002078_abnormal_glucose_homeostasis | 0.55374629 |
| 122 | MP0005023_abnormal_wound_healing | 0.54317999 |
| 123 | MP0003866_abnormal_defecation | 0.54310522 |
| 124 | MP0004883_abnormal_blood_vessel | 0.50499784 |
| 125 | MP0003953_abnormal_hormone_level | 0.49618755 |
| 126 | MP0005334_abnormal_fat_pad | 0.48431227 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.47537776 |
| 128 | MP0009115_abnormal_fat_cell | 0.44728070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.30854007 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.57129479 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.28495027 |
| 4 | Gout (HP:0001997) | 4.25393469 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.20397325 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.17375933 |
| 7 | Xanthomatosis (HP:0000991) | 3.98111888 |
| 8 | Complement deficiency (HP:0004431) | 3.64568637 |
| 9 | Abnormality of purine metabolism (HP:0004352) | 3.54528085 |
| 10 | Hyperactive renin-angiotensin system (HP:0000841) | 3.53217627 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 3.42010009 |
| 12 | Hyperglycinuria (HP:0003108) | 3.39610184 |
| 13 | Ketosis (HP:0001946) | 3.37366218 |
| 14 | Hyperammonemia (HP:0001987) | 3.34080335 |
| 15 | Generalized aminoaciduria (HP:0002909) | 3.30302455 |
| 16 | Hydroxyprolinuria (HP:0003080) | 3.27949855 |
| 17 | Abnormality of proline metabolism (HP:0010907) | 3.27949855 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19053926 |
| 19 | Joint hemorrhage (HP:0005261) | 3.18323935 |
| 20 | Hypokalemic alkalosis (HP:0001949) | 3.15109950 |
| 21 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07287353 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.03252986 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.02853310 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.01898584 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.01898584 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.01629475 |
| 27 | Ketoacidosis (HP:0001993) | 2.99490826 |
| 28 | Alkalosis (HP:0001948) | 2.97891303 |
| 29 | Abnormality of chloride homeostasis (HP:0011422) | 2.93443271 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 2.93282418 |
| 31 | Proximal tubulopathy (HP:0000114) | 2.93119145 |
| 32 | Vascular calcification (HP:0004934) | 2.90738075 |
| 33 | Increased purine levels (HP:0004368) | 2.90284589 |
| 34 | Hyperuricemia (HP:0002149) | 2.90284589 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 2.89654964 |
| 36 | Purpura (HP:0000979) | 2.88166143 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84927865 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84927865 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84927865 |
| 40 | Abnormality of complement system (HP:0005339) | 2.83546800 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.83487771 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.79105179 |
| 43 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.79105179 |
| 44 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.79105179 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.77817587 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 2.76478631 |
| 47 | Hyperglycinemia (HP:0002154) | 2.76166603 |
| 48 | Esophageal varix (HP:0002040) | 2.72747768 |
| 49 | Delayed CNS myelination (HP:0002188) | 2.70996003 |
| 50 | Cardiovascular calcification (HP:0011915) | 2.64047694 |
| 51 | Fat malabsorption (HP:0002630) | 2.63271412 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.62129253 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.60078182 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.58660811 |
| 55 | Increased circulating renin level (HP:0000848) | 2.55948925 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.54749036 |
| 57 | Abnormality of renal excretion (HP:0011036) | 2.54623627 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.52797329 |
| 59 | Renal salt wasting (HP:0000127) | 2.49504576 |
| 60 | Potter facies (HP:0002009) | 2.47863299 |
| 61 | Facial shape deformation (HP:0011334) | 2.47863299 |
| 62 | Abnormal urine output (HP:0012590) | 2.45194776 |
| 63 | Abnormality of vitamin metabolism (HP:0100508) | 2.42640593 |
| 64 | Glycosuria (HP:0003076) | 2.38400019 |
| 65 | Abnormality of urine glucose concentration (HP:0011016) | 2.38400019 |
| 66 | Metabolic acidosis (HP:0001942) | 2.37298204 |
| 67 | Metabolic alkalosis (HP:0200114) | 2.37275552 |
| 68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36290316 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.36290316 |
| 70 | Pulmonary embolism (HP:0002204) | 2.33748600 |
| 71 | Polyuria (HP:0000103) | 2.33266342 |
| 72 | Glomerulonephritis (HP:0000099) | 2.30788284 |
| 73 | Hypomagnesemia (HP:0002917) | 2.29808827 |
| 74 | Hypolipoproteinemia (HP:0010981) | 2.29357996 |
| 75 | Hepatocellular carcinoma (HP:0001402) | 2.26574149 |
| 76 | Gingival bleeding (HP:0000225) | 2.25501868 |
| 77 | Late onset (HP:0003584) | 2.25071008 |
| 78 | Abnormality of renin-angiotensin system (HP:0000847) | 2.23614772 |
| 79 | Thrombophlebitis (HP:0004418) | 2.22456104 |
| 80 | Hypophosphatemia (HP:0002148) | 2.21477243 |
| 81 | Myocardial infarction (HP:0001658) | 2.20767741 |
| 82 | Hyperbilirubinemia (HP:0002904) | 2.20551023 |
| 83 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19061350 |
| 84 | Hyperaldosteronism (HP:0000859) | 2.18694040 |
| 85 | Polycythemia (HP:0001901) | 2.17500521 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17452034 |
| 87 | Epidermoid cyst (HP:0200040) | 2.16725560 |
| 88 | Irritability (HP:0000737) | 2.16277964 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 2.15391368 |
| 90 | Widely patent fontanelles and sutures (HP:0004492) | 2.14973097 |
| 91 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.14236349 |
| 92 | Abnormality of magnesium homeostasis (HP:0004921) | 2.13219366 |
| 93 | Amyloidosis (HP:0011034) | 2.12921658 |
| 94 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.12823583 |
| 95 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12805889 |
| 96 | Nephrolithiasis (HP:0000787) | 2.12246136 |
| 97 | Pancreatitis (HP:0001733) | 2.08680643 |
| 98 | Spontaneous abortion (HP:0005268) | 2.08493974 |
| 99 | Increased serum ferritin (HP:0003281) | 2.04886014 |
| 100 | Steatorrhea (HP:0002570) | 2.04423251 |
| 101 | Renal tubular acidosis (HP:0001947) | 2.04369559 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.03550259 |
| 103 | Nephritis (HP:0000123) | 2.03312275 |
| 104 | Abnormality of macrophages (HP:0004311) | 2.01463767 |
| 105 | Spontaneous hematomas (HP:0007420) | 1.99618010 |
| 106 | Increased CSF protein (HP:0002922) | 1.98727612 |
| 107 | Malnutrition (HP:0004395) | 1.97982130 |
| 108 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.96643838 |
| 109 | Tetany (HP:0001281) | 1.96399660 |
| 110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95912237 |
| 111 | Hypercholesterolemia (HP:0003124) | 1.95805292 |
| 112 | Mucopolysacchariduria (HP:0008155) | 1.95750335 |
| 113 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95750335 |
| 114 | Osteomalacia (HP:0002749) | 1.95566047 |
| 115 | Hyperphosphaturia (HP:0003109) | 1.94218371 |
| 116 | Eczematoid dermatitis (HP:0000976) | 1.93488514 |
| 117 | Abnormality of the nasal mucosa (HP:0000433) | 1.93057894 |
| 118 | Vomiting (HP:0002013) | 1.92623771 |
| 119 | Mitral stenosis (HP:0001718) | 1.92545813 |
| 120 | Enlarged kidneys (HP:0000105) | 1.91610694 |
| 121 | Rickets (HP:0002748) | 1.91079980 |
| 122 | Menorrhagia (HP:0000132) | 1.90105524 |
| 123 | Thrombocytosis (HP:0001894) | 1.88642710 |
| 124 | Lethargy (HP:0001254) | 1.88611206 |
| 125 | Protuberant abdomen (HP:0001538) | 1.87326673 |
| 126 | Orchitis (HP:0100796) | 1.84149969 |
| 127 | Progressive neurologic deterioration (HP:0002344) | 1.82134329 |
| 128 | Congenital sensorineural hearing impairment (HP:0008527) | 1.81819096 |
| 129 | Loss of speech (HP:0002371) | 1.81587466 |
| 130 | Reduced antithrombin III activity (HP:0001976) | 1.81396674 |
| 131 | Elevated alkaline phosphatase (HP:0003155) | 1.81041513 |
| 132 | Stroke (HP:0001297) | 1.79725725 |
| 133 | Abdominal distention (HP:0003270) | 1.79224810 |
| 134 | Prolonged neonatal jaundice (HP:0006579) | 1.78472136 |
| 135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77438476 |
| 136 | Abnormality of vitamin B metabolism (HP:0004340) | 1.77226323 |
| 137 | Nausea (HP:0002018) | 1.77216904 |
| 138 | Skin nodule (HP:0200036) | 1.76887407 |
| 139 | Increased cerebral lipofuscin (HP:0011813) | 1.76275740 |
| 140 | Retinal atrophy (HP:0001105) | 1.75993940 |
| 141 | Petechiae (HP:0000967) | 1.74440774 |
| 142 | Abnormal gallbladder physiology (HP:0012438) | 1.73847287 |
| 143 | Cholecystitis (HP:0001082) | 1.73847287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.94029338 |
| 2 | BCKDK | 3.59635840 |
| 3 | ACVR1B | 3.42354744 |
| 4 | FGFR4 | 3.09512261 |
| 5 | TGFBR2 | 2.63789051 |
| 6 | TIE1 | 2.49450715 |
| 7 | TAOK3 | 2.37747113 |
| 8 | TBK1 | 2.37255178 |
| 9 | MAP3K14 | 2.36553193 |
| 10 | WNK4 | 2.35771822 |
| 11 | TYK2 | 2.30005179 |
| 12 | FLT3 | 2.14537610 |
| 13 | EPHB1 | 1.99585577 |
| 14 | KDR | 1.95354247 |
| 15 | MAPK15 | 1.93198870 |
| 16 | NEK9 | 1.91658898 |
| 17 | SIK1 | 1.91194309 |
| 18 | EPHA3 | 1.85394587 |
| 19 | GRK7 | 1.78669462 |
| 20 | IKBKE | 1.77956914 |
| 21 | TRIB3 | 1.74259692 |
| 22 | IRAK3 | 1.72219332 |
| 23 | JAK3 | 1.68419369 |
| 24 | TGFBR1 | 1.68071482 |
| 25 | KIT | 1.66727922 |
| 26 | WNK3 | 1.60296444 |
| 27 | DDR2 | 1.54438830 |
| 28 | CDC42BPA | 1.49531347 |
| 29 | ZAP70 | 1.48664213 |
| 30 | MAP4K1 | 1.48429442 |
| 31 | JAK1 | 1.46824824 |
| 32 | PTK6 | 1.46569363 |
| 33 | TAOK1 | 1.42586913 |
| 34 | IKBKB | 1.41080214 |
| 35 | FRK | 1.40820122 |
| 36 | PRPF4B | 1.36418817 |
| 37 | MAP2K3 | 1.34788426 |
| 38 | MYLK | 1.33002423 |
| 39 | LRRK2 | 1.31520403 |
| 40 | MAP3K3 | 1.30126978 |
| 41 | MST1R | 1.29946254 |
| 42 | INSRR | 1.29418844 |
| 43 | TNK2 | 1.27760903 |
| 44 | CHUK | 1.25509594 |
| 45 | RIPK4 | 1.23900609 |
| 46 | TEC | 1.22610625 |
| 47 | ADRBK2 | 1.22317076 |
| 48 | TESK1 | 1.20814525 |
| 49 | BTK | 1.20560811 |
| 50 | PKN2 | 1.19110505 |
| 51 | DAPK2 | 1.19032219 |
| 52 | IRAK4 | 1.17908840 |
| 53 | RIPK1 | 1.16919720 |
| 54 | MST4 | 1.15227920 |
| 55 | BLK | 1.12369194 |
| 56 | IRAK1 | 1.12057624 |
| 57 | PDPK1 | 1.10689769 |
| 58 | OXSR1 | 1.05310614 |
| 59 | DYRK1B | 1.03308122 |
| 60 | JAK2 | 1.03022188 |
| 61 | MAP3K2 | 0.98008787 |
| 62 | NLK | 0.96390227 |
| 63 | PIK3CG | 0.95893555 |
| 64 | PIK3CA | 0.93219394 |
| 65 | PRKACG | 0.91196180 |
| 66 | FGFR3 | 0.90849824 |
| 67 | PIM2 | 0.90207383 |
| 68 | TAOK2 | 0.89578697 |
| 69 | NME2 | 0.87984226 |
| 70 | MATK | 0.86515291 |
| 71 | PTK2 | 0.85772258 |
| 72 | CSF1R | 0.84520560 |
| 73 | MAPK11 | 0.81920519 |
| 74 | PAK4 | 0.81456597 |
| 75 | PDK1 | 0.77346098 |
| 76 | PRKG2 | 0.74589513 |
| 77 | FER | 0.74106887 |
| 78 | MAP2K2 | 0.71880978 |
| 79 | MAP2K6 | 0.71785834 |
| 80 | EPHB2 | 0.71565337 |
| 81 | PRKAA2 | 0.71181725 |
| 82 | MAP3K7 | 0.70121225 |
| 83 | CSK | 0.69434927 |
| 84 | EPHA2 | 0.68070895 |
| 85 | GSK3A | 0.63582967 |
| 86 | PRKD2 | 0.62369282 |
| 87 | MAP3K11 | 0.60019854 |
| 88 | MAP3K12 | 0.59636717 |
| 89 | MAPK7 | 0.57931026 |
| 90 | MAP3K1 | 0.57451084 |
| 91 | MAP3K13 | 0.53908676 |
| 92 | LATS1 | 0.53829241 |
| 93 | NTRK3 | 0.53639129 |
| 94 | ABL2 | 0.53252391 |
| 95 | PRKCZ | 0.53027783 |
| 96 | STK38L | 0.51721502 |
| 97 | PRKCA | 0.49989323 |
| 98 | PIM1 | 0.49331955 |
| 99 | GRK6 | 0.49252492 |
| 100 | MAPKAPK3 | 0.48613827 |
| 101 | BMPR2 | 0.48167621 |
| 102 | TXK | 0.47809096 |
| 103 | SYK | 0.47799268 |
| 104 | ITK | 0.46642287 |
| 105 | PDK2 | 0.46114114 |
| 106 | FGR | 0.43953495 |
| 107 | STK24 | 0.43772911 |
| 108 | CDK6 | 0.43759903 |
| 109 | SRC | 0.43206542 |
| 110 | IGF1R | 0.43016524 |
| 111 | CAMK2D | 0.42615693 |
| 112 | CAMKK2 | 0.41106256 |
| 113 | SCYL2 | 0.40759452 |
| 114 | PRKCG | 0.40135728 |
| 115 | HIPK2 | 0.39554351 |
| 116 | PRKCD | 0.38867893 |
| 117 | PRKCE | 0.38699704 |
| 118 | LYN | 0.38657723 |
| 119 | ERBB4 | 0.38254515 |
| 120 | RPS6KA4 | 0.38015859 |
| 121 | ERBB2 | 0.37220509 |
| 122 | MAPK4 | 0.37103595 |
| 123 | PRKG1 | 0.36422665 |
| 124 | LCK | 0.35353843 |
| 125 | PDGFRA | 0.34754016 |
| 126 | STK10 | 0.33842562 |
| 127 | FES | 0.33648421 |
| 128 | PRKACA | 0.33218419 |
| 129 | NUAK1 | 0.33124604 |
| 130 | ABL1 | 0.31146032 |
| 131 | RET | 0.30753904 |
| 132 | GRK1 | 0.30136676 |
| 133 | CAMK1D | 0.29406508 |
| 134 | IRAK2 | 0.27676973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.55410963 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.37444330 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.89979840 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.79626473 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63607689 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56676284 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.53815427 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50806508 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32694135 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22163142 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.20616118 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18326896 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15373274 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09754476 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94962269 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89869676 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89269695 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86706356 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84846531 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83408643 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82811837 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.77855590 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76813414 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.73956153 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73866774 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68646717 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64810229 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61409529 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.57156516 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51516506 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.48293678 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46887819 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45282967 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45109582 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.39727244 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38303400 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35429465 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.34524934 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30128821 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30078306 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29563245 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25984763 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18707194 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14417479 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13301687 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10540606 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.10352545 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05349373 |
| 49 | Mineral absorption_Homo sapiens_hsa04978 | 1.02612850 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00305792 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97946119 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95715207 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95044832 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93042928 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92849777 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92279606 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89475649 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85792755 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85609539 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72498970 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68593065 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68262008 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63958578 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63161877 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.62710343 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.60482603 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59392947 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59309207 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59085366 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56398639 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55664191 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54084643 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53736624 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53516220 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.51427916 |
| 76 | Allograft rejection_Homo sapiens_hsa05330 | 0.50704930 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47536533 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46444325 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43785092 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42192914 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41579368 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41381660 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.41054222 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40415417 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39478246 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.39451931 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39411901 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.38882217 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.36535282 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36170915 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36149117 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.34353134 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.33316577 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31808589 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.31476927 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30178809 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.29670705 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29378450 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29266397 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29045616 |
| 101 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.27189963 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25662835 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25520539 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.25447537 |
| 105 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24675238 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | 0.24537856 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24083782 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19873231 |
| 109 | Measles_Homo sapiens_hsa05162 | 0.18760049 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17550566 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.16911373 |
| 112 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.16707622 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16602439 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.16131756 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.15414074 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.15170053 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15031011 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.14800571 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.14717169 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13647982 |

